SecBot SecBot
SECBOTREPLAY Home › Report › MRK

MRK · In the Zostavax MDL pending in the Eastern District of Pennsylvania,…

Merck & Co., Inc. · COURT-RULING filed Apr 7, 2026 at 20:00 ET

At the news

BULLISHIMPACT 5/10

COURT-RULING filed Apr 7, 2026 at 20:00 ET

In the Zostavax MDL pending in the Eastern District of Pennsylvania, Judge Bartle granted Merck's motion to dismiss with prejudice 295 product-liability cases for failure to comply with discovery deadlines (PTO 526). Over the course of the eight-year MDL, no plaintiff had ever produced admissible expert testimony supporting causation. This ruling permanently terminates nearly all remaining case inventory from the Zostavax litigation and removes a long-tail contingent liability for Merck.

  • 295 product-liability cases dismissed with prejudice
  • MDL designated August 2, 2018, now in its eighth year
  • No plaintiff has ever successfully presented expert testimony on causation
  • Only one counsel filed a response on behalf of 47 plaintiffs, merely asking for more time

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access